Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

1.4K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.4K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

654
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
654
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

758
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
758
Dialysis01:27

Dialysis

1.2K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.2K
Dialysis01:15

Dialysis

1.6K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

2.5K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arteriovenous fistula creation results in cardiac dysfunction and remodeling in a uremic pig model.

American journal of physiology. Renal physiology·2026
Same author

Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Comparative Epidemiology of KRT in the United States and Israel.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Mitochondrial DNA is an important signaling molecule in cardiovascular aging and pathophysiology.

American journal of physiology. Heart and circulatory physiology·2026
Same author

The Role of Analysis Populations and Estimands in Clinical Trials.

Journal of the American Society of Nephrology : JASN·2026
Same author

Launching Kidney360: Reflections on an Editorial Journey as We Pass the Torch.

Kidney360·2025
Same journal

Muscle Cramp Rate, Severity and Burden in Maintenance Hemodialysis Patients: A Yearlong Multicenter Quality Improvement Initiative.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

From Risk Determinants to Clinical Action: Understanding and Implementing the Cardiovascular Kidney Metabolic Syndrome Framework.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Preserving Peritoneal Membrane Performance.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Reimagining Nephrology Training in a Cardiovascular-Kidney-Metabolic Framework.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Prospective Cohort Study Evaluating Impact of Hemodialysis on Glycemia: BLOSSOM (Blood Sugar Sensing on Maintenance Dialysis) Cohort Findings.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

IgA Nephropathy Across the Age Spectrum: Urgent Need to Accelerate Pediatric Access to Therapeutic Innovation.

Clinical journal of the American Society of Nephrology : CJASN·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

A Modified Technique for Arteriovenous Fistula Construction in Rabbits
05:00

A Modified Technique for Arteriovenous Fistula Construction in Rabbits

Published on: February 10, 2023

1.8K

Optimizing Dialysis Vascular Access: Moving beyond Fistula First.

Michael Allon1, Carton J Young2, Timmy Lee1,3

  • 1Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama.

Clinical Journal of the American Society of Nephrology : CJASN
|September 8, 2025
PubMed
Summary
This summary is machine-generated.

The "Fistula First" strategy for hemodialysis access may not be optimal for all patients. A more selective approach, prioritizing arteriovenous grafts (AVGs) for high-risk individuals, can reduce procedures and costs.

Keywords:
arteriovenous accessarteriovenous fistulaarteriovenous graft

More Related Videos

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
07:30

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

8.9K

Related Experiment Videos

Last Updated: Jan 18, 2026

A Modified Technique for Arteriovenous Fistula Construction in Rabbits
05:00

A Modified Technique for Arteriovenous Fistula Construction in Rabbits

Published on: February 10, 2023

1.8K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
07:30

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

8.9K

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Dialysis Access Management

Background:

  • Historically, arteriovenous fistulas (AVFs) were preferred over arteriovenous grafts (AVGs) due to better long-term outcomes and lower costs.
  • Recent evidence challenges the universal
  • Fistula First
  • strategy, highlighting significant AVF nonmaturation rates (30-40%) and complications.

Purpose of the Study:

  • To evaluate the effectiveness of the
  • Fistula First
  • strategy versus a more selective approach to vascular access placement in hemodialysis patients.
  • To compare procedural frequency and cost of access management between AVFs and AVGs.

Main Methods:

  • Review of existing research and guidelines on vascular access placement.
  • Analysis of outcomes including AVF nonmaturation rates, intervention requirements, and cost-effectiveness.
  • Comparison of
  • Fistula First
  • strategy with a selective strategy favoring AVGs in high-risk patients.

Main Results:

  • AVF nonmaturation is substantial, particularly in women, older adults, and those with peripheral vascular disease.
  • Assisted maturation of AVFs leads to poorer outcomes and increased interventions.
  • A selective strategy, prioritizing AVGs for high-risk patients, is associated with fewer procedures and lower annual access management costs.

Conclusions:

  • The
  • Fistula First
  • strategy may not be universally optimal.
  • A patient-centered, selective approach to vascular access (AVF vs. AVG) can improve outcomes, reduce procedural burden, and lower costs.
  • The 2019 Kidney Disease Outcomes Quality Initiative guidelines advocate for personalized vascular access selection.